Avanir Pharmaceuticals
Avanir Pharmaceuticals, Inc.
30 Enterprise, Suite 400
Aliso Viejo, CA 92656
Phone: (949) 389 6700Website: https://www.avanir.com/Careers: www.avanir.com/careersPatient Assistance Program: www.avanir.com/patient-resources
Latest news
- FDA Approves Onzetra Xsail (sumatriptan nasal powder) for the Acute Treatment of Migraine
28 January 2016 - Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA
26 November 2014 - Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine
7 November 2014 - Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study
30 October 2014 - Avanir Pharmaceuticals Announces Acceptance of NDA for AVP-825 for the Acute Treatment of Migraine
26 March 2014 - Avanir Pharmaceuticals Announces Submission of New Drug Application for AVP-825 for the Acute Treatment of Migraine
30 January 2014
Drugs Associated with Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Nuedexta
Generic name: dextromethorphan/quinidine Drug class: miscellaneous central nervous system agents |
23 reviews | 8.9 / 10 |
|
Onzetra Xsail
Generic name: sumatriptan Drug class: antimigraine agents |
5 reviews | 6.2 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
